Agenda
Saturday, August 14, 2010
Pasadena, CA
| 7:30AM | Breakfast and Registrations | |
| 8:25AM | Welcome and Introductions | |
| Adjuvant Therapy and Multimodality Therapy for Lung Cancer Session Chair and Moderator: Chandra P. Belani, MD |
||
| 8:30AM | State of the Art and Integration of Novel Agents in the Treatment of Lung Cancer | Heather Wakelee, MD |
| 8:55 AM | Management of Stage III Disease: Multimodality Therapy | Hak Choy, MD |
| 9:20 AM | Small Cell Lung Cancer: Novel Agents and Recent Advances | Ronald Natale, MD |
| 9:45 AM | Panel Discussion and Case Presentations | Heather Wakelee, MD/ David Jablons, MD/Hak Choy, MD |
| 10:05AM | BREAK | |
| Targeting VEGF and EGFR Receptors in Lung Cancer Session Chair and Moderator: Suresh Ramalingam, MD |
||
| 10:15AM | State of the ART of Targeting VEGF Receptors in Lung Cancer | Ronald Natale, MD |
| 10:40AM | EGFR Inhibitors - Optimal Usage & Biomarkers for Patient Selection | Suresh Ramalingam, MD |
| Novel Treatment Options for Lung Cancer and Head & Neck Cancer Session Chair-Chandra P. Belani, MD |
||
| 11:05AM | Role of Maintenance Therapy in Lung Cancer - Debate | Pro: Chandra P. Belani, MD |
| 11:30AM | Role of Maintenance Therapy in Lung Cancer - Debate | Con: Afshin Dowlati, MD |
| 11:55AM | Panel Discussion and Case Presentations | Ronald Natale, MD/ Suresh Ramalingam, MD/ Chandra P. Belani, MD/ Afshin Dowlati, MD |
| 12:15PM | LUNCH | |
| 1:00PM | Current Strategies in the Treatment of Head & Neck Cancers | Ezra Cohen, MD |
| 1:25PM | Second-line Treatment Options for Lung Cancer | Shirish Gadgeel, MD |
| 1:50PM | Novel Agents for Small Cell and Non-Small Cell Lung Cancer: HDAC Inhibitors, Nab-Paclitaxel, IGF-1R targeted agents, Hedgehog inhibitors, met Inhibitors |
Patricia LoRusso, DO |
| 2:15 PM | Panel Discussion and Case Presentations | Chandra P. Belani, MD/ Shirish Gadgeel, MD/ Patricia LoRusso, DO |
| 2:35PM | Closing Remarks and Adjourn | Chandra P. Belani, MD |